Home/Filings/4/0001601712-25-000107
4//SEC Filing

Juel Carol 4

Accession 0001601712-25-000107

CIK 0001601712other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 7:20 PM ET

Size

22.7 KB

Accession

0001601712-25-000107

Insider Transaction Report

Form 4
Period: 2025-03-01
Juel Carol
See remarks
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-03-0318,1450 total
    Exercise: $33.53Exp: 2028-04-01Common Stock (18,145 underlying)
  • Award

    Common Stock

    2025-03-01$60.68/sh+24,102$1,462,509129,923 total
  • Tax Payment

    Common Stock

    2025-03-01$60.68/sh15,518$941,632114,405 total
  • Exercise/Conversion

    Common Stock

    2025-03-03$34.30/sh+16,613$569,826131,018 total
  • Exercise/Conversion

    Common Stock

    2025-03-03$33.53/sh+18,145$608,402149,163 total
  • Sale

    Common Stock

    2025-03-03$57.43/sh13,177$756,755135,986 total
  • Sale

    Common Stock

    2025-03-03$58.57/sh12,367$724,335123,619 total
  • Sale

    Common Stock

    2025-03-03$59.29/sh46,102$2,733,38877,517 total
  • Sale

    Common Stock

    2025-03-03$60.49/sh19,404$1,173,74858,113 total
  • Sale

    Common Stock

    2025-03-03$61.13/sh363$22,19057,750 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-03-0316,6130 total
    Exercise: $34.30Exp: 2027-04-01Common Stock (16,613 underlying)
Footnotes (10)
  • [F1]Represents restricted stock units that will vest in three equal annual installments of 33.33% each, beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial (the "Company") common stock.
  • [F10]The reporting person was awarded employee stock options on April 1, 2018, which vest in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.
  • [F2]Reflects the number of shares of Company common stock automatically withheld by the Company to pay the tax liability of the reporting person in connection with the vesting of restricted stock units. No investment decision was made by the reporting person in connection with the withholding.
  • [F3]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024.
  • [F4]This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.96 to $57.87. Information regarding the number of shares sold at each price will be provided upon request.
  • [F5]This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.98 to $58.92. Information regarding the number of shares sold at each price will be provided upon request.
  • [F6]This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.96 to $59.95. Information regarding the number of shares sold at each price will be provided upon request.
  • [F7]This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.96 to $60.93. Information regarding the number of shares sold at each price will be provided upon request.
  • [F8]This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.05 to $61.19. Information regarding the number of shares sold at each price will be provided upon request.
  • [F9]The reporting person was awarded employee stock options on April 1, 2017, which vest in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.

Issuer

Synchrony Financial

CIK 0001601712

Entity typeother

Related Parties

1
  • filerCIK 0001868897

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:20 PM ET
Size
22.7 KB